Old Web
English
Sign In
Acemap
>
authorDetail
>
Evren Zor
Evren Zor
Novartis
Internal medicine
Medicine
Gastroenterology
Anemia
Ruxolitinib
7
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
2021
Leukemia
Francisco Cervantes
David M. Ross
Atanas Radinoff
Francesca Palandri
Alexandr Myasnikov
Alessandro M. Vannucchi
Pierre Zachee
Heinz Gisslinger
Norio Komatsu
Lynda M Foltz
Francesco Mannelli
Francesco Passamonti
Geralyn Gilotti
Islam Sadek
Ranjan Tiwari
Evren Zor
Haifa Kathrin Al-Ali
Show All
Source
Cite
Save
Citations (1)
Analysis of predictors of response to ruxolitinib in patients with myelofibrosis in the phase 3b expanded-access JUMP study.
2020
Leukemia & Lymphoma
Vikas Gupta
Martin Griesshammer
Bruno Martino
Lynda M Foltz
Renato S Tavares
Haifa Kathrin Al-Ali
Pilar Giraldo
Paola Guglielmelli
Elza Lomaia
Catherine Bouard
Carole Paley
Ranjan Tiwari
Evren Zor
Pia Raanani
Show All
Source
Cite
Save
Citations (1)
Prevalence of Cardiac and Hepatic Siderosis in Australian Patients with Transfusion-Dependent Anemias or Non-Transfusion-Dependent Thalassemia, As Assessed By MRI (the TIMES study)
2015
Blood
Phoebe Joy Ho
Devendra K. Hiwase
Raj Ramakrishna
Nicholas Viiala
David M. Ross
Evren Zor
Othon L. Gervasio
Donald K. Bowden
Show All
Source
Cite
Save
Citations (0)
1